Category Archives: Stem Cell Treatment

Autologous Stem Cell and Non-Stem Cell Based Therapies Market – Growth, Trends, and Forecast (2020 – 2025) – GlobeNewswire

September 22, 2020 04:03 ET | Source: ReportLinker

New York, Sept. 22, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Autologous Stem Cell and Non-Stem Cell Based Therapies Market – Growth, Trends, and Forecast (2020 – 2025)” – https://www.reportlinker.com/p05974135/?utm_source=GNW

– Stem cell technology is found to be a speedily developing technology which plays a major role in regenerative medicine, as it also serves the disciplines of tissue engineering, developmental cell biology, cellular therapeutics, gene therapy, chemical biology, and nanotechnology. Stem cells offer the possibility of replacing the cells and tissues to treat various conditions including spinal cord injury, arthritis, and Parkinsons disease, among others. – The applications of stem cell technologies in the treatment of diseases have ultimately increased the overall adoption rate of these technologies across the world. – The advantage of autologous stem cell transplant is that one is getting ones own cells back. This means there is no risk that the immune system of the individual will reject the transplant or that the transplanted cells will attack or reject the individuals body.

Key Market Trends Cancer Holds Significant Share in the Autologous Stem Cell and Non-Stem Cell Based Therapies Market

– Cancer rates could further increase by 50%, to 15 million new cases by 2020, as per World Cancer Report. It also provides clear evidence that healthy lifestyles and public health action by governments and health practitioners could stem this trend, and prevent as many as one-third of cancers, worldwide. – The American Cancer Society, the leading body in cancer stats and figures, reports 1,685,210 estimated new cancer cases and 595,690 deaths due to cancer in 2016, in the United States. – The National Cancer Institute reports that more than 60% of the worlds new cancer cases occur in Africa, Asia, and Central and South America; 70% of the worlds cancer deaths also occur in these regions. The International Agency for Research on Cancer (IARC) predicts that by 2030, the global burden is expected to rise to 21.7 million new cancer cases and 13 million cancer deaths, simply due to growth and aging of population, leaving aside factors, such as smoking, poor diet, physical inactivity, and fewer childbirths in economically developing countries. – According to WHO, almost 70% of deaths from cancer occur in low and middle-income countries, and only one in five low- and middle-income countries has the necessary data to drive cancer policy. This global and extensive threat of cancer remains a major market driver for new cancer therapies that help in risk assessment, early diagnosis, and effective monitoring of the treatment.

North America Dominates the Autologous Stem Cell and Non-Stem Cell Based Therapies Market

– North America dominated the overall stem cell market with the United States contributing to the largest share in the market. – The ease in the US government regulations and availability of funds from various organizations, like the National Institute of Health, have provided the potential for researchers to invest more in the use of biomarkers in drug discovery, drug development, detection of specific tumors, monitoring biological response to cancer therapy, and genetic studies for the identification of predisposed candidates of cancer. – In 2014, the Sanford Stem Cell Clinical Center at the University of California, San Diego (UCSD) Health System, announced the launch of a clinical trial, in order to assess the safety of neural stem cellbased therapy in patients with chronic spinal cord injury. – Researchers hoped that the transplanted stem cells may develop into new neurons that could replace severed or lost nerve connections, and restore at least some motor and sensory functions. Such numerous stem cell studies across the United States have helped in the growth of the stem cell market.

Competitive Landscape The global Autologous Stem Cell and Non-Stem Cell-Based Therapies market is competitive and consists of a few major players. The companies includes Novartis AG, BrainStorm Cell Limited, Caladrius, Cytori Therapeutics Inc., Dendreon Pharmaceuticals LLC, Gilead Sciences Inc., Regeneus Ltd, U.S. Stem Cell, Inc, among others, hold the substantial market share in the growth of overall market.

Reasons to Purchase this report: – The market estimate (ME) sheet in Excel format – 3 months of analyst support Read the full report: https://www.reportlinker.com/p05974135/?utm_source=GNW

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

Read more here:
Autologous Stem Cell and Non-Stem Cell Based Therapies Market – Growth, Trends, and Forecast (2020 – 2025) – GlobeNewswire

Cell Therapy Market – Global Size, Share, Trends and Key Players (2020-2025) – News by aeresearch

The report, titled Cell Therapy Market, is a comprehensive document that provides valuable insights into market elements like drivers, restraints, competitive landscape, and technology evolution. For a better understanding of the market, the report offers a comprehensive analysis of the key segments and future growth prospects. The current COVID-19 pandemic has significantly changed market dynamics and the global economy. The report provides an impact analysis of the pandemic on the entire market. It also provides an analysis of the current and future impact. The report provides a comprehensive analysis of the dynamic changes in trends and requirements due to the COVID-19 pandemic. The report also includes a post-COVID scenario and prospects for future growth.

The research report on Cell Therapy market encloses a complete examination of present and future scenario of this industry domain. It mentions the growth driving factors and opportunities which will help in industry expansion, as well as the challenges that will hamper the market growth.

The report offers historic as well as current data on various market segmentations to determine key products, applications, and end-users impacting the business revenue. It also highlights and market share and growth rate of the industry over the analysis period. Besides, the study contains pricing models and consumption patterns of this business space.

Request Sample Copy of this Report @ https://www.aeresearch.net/request-sample/311593

Questions about the regional terrain that are answered in the Cell Therapy market report:

Other vital pointers in the Cell Therapy market report:

Key Reasons to Purchase

Request Customization on This Report @ https://www.aeresearch.net/request-for-customization/311593

Continue reading here:
Cell Therapy Market – Global Size, Share, Trends and Key Players (2020-2025) – News by aeresearch

OncoImmune’s SACCOVID (CD24Fc) Exhibits Superb Therapeutic EfficacyA Potential Breakthrough in Treating Severe and Critical COVID-19 – Business Wire

ROCKVILLE, Md.–(BUSINESS WIRE)–OncoImmune Inc. today announced that it has closed enrollment of the Phase III SAC-COVID clinical trial (NCT04317040) and releases topline results from the pre-planned interim efficacy analysis. Data from 203 participants (75% of the planned enrollment) show that severe or critical COVID-19 patients treated with SACCOVIDTM exhibited significantly faster recovery and significantly reduced disease progression to death or respiratory failure than those receiving placebo, when used in conjunction with the standard of care (SOC).

The SAC-COVID Phase III clinical trial is randomized, placebo-controlled and blinded to participants, the clinical teams, the investigators, and the Sponsor. Hospitalized COVID-19 patients who required oxygen support, including those requiring supplemental oxygen, high flow oxygen, and non-invasive ventilation were randomly assigned into two arms receiving either SOC plus a single dose of SACCOVIDTM or SOC plus placebo. The trial had a planned enrollment of 270 patients. The pre-specified interim efficacy and safety analyses were performed when 146 patients achieved clinical recovery from COVID-19, a milestone achieved with 203 enrollments. The trial was opened in April this year and was activated in 15 medical centers in the US.

The interim analysis shows safety and outstanding therapeutic efficacy of SACCOVIDTM. The results indicate that patients who received SACCOVIDTM had a 60% better chance to achieve clinical recovery than those who received placebo (P=0.005). The median time to recovery was 6 days for patients treated with SACCOVIDTM compared with 10 days in the placebo group. In addition, the risk of death or respiratory failure is reduced by more than 50%, said Dr. Pan Zheng, MD, PhD, Chief Medical Officer and co-founder of OncoImmune. Since the trial did not exclude other experimental therapeutics, many participants also received Remdesivir and/or corticosteroids including dexamethasone. Among them, those who were treated with SACCOVIDTM and Remdesivir recovered 7 days earlier than those who received Remdesivir and placebo (median time to recovery 6 days vs 13 days). Those who were treated with SACCOVIDTM and corticosteroids recovered 10 days earlier than those who received corticosteroids and placebo (median time to recovery 5 days vs 15 days). More detailed information about the trial results will be released as soon as the study is submitted to peer-reviewed medical journals.

The very large therapeutic effect of SACCOVIDTM observed potentially represents a major breakthrough in COVID-19 therapy. We took a novel approach to fortify an innate immune checkpoint we discovered, having previously demonstrated efficacy in a nonhuman primate model for treating viral pneumonia, and applied this to SARS-CoV-2. We are exhilarated that this approach appears to have led to unparalleled efficacy. OncoImmune is focusing on expanding drug supply and regulatory approval to make the drug available to COVID-19 patients, said Yang Liu, PhD, Co-founder and Chief Executive Officer.

SACCOVIDTM (known as CD24Fc during its development by OncoImmune, Inc.), is an investigational immunomodulator targeting the innate immune system. CD24Fc has been studied for safety in healthy volunteers and in Phase II clinical trials for the prevention of graft versus host disease (GVHD) following hematopoietic stem cell transplantation in leukemia patients, where it also showed therapeutic efficacy. The Phase III SAC-COVID clinical trial is partially funded through a grant from the National Cancer Institute.

About OncoImmune, Inc.

OncoImmune (www.oncoimmune.com) is a privately-held, clinical-stage biopharmaceutical company focusing on the discovery and development of novel immunotherapies for cancer, inflammation and autoimmune diseases. OncoImmune is based in Rockville, Maryland.

OncoImmunes lead program, CD24Fc, develops novel therapeutic products based on CD24Fc that regulates host inflammatory response to tissue injuries and may have broadly applicable to cancer, autoimmune disease, metabolic syndrome and graft-versus-host disease (GVHD). OncoImmune has completed a Phase IIa trial using CD24Fc to treat leukemia patients undergoing hematopoietic stem cell transplantation (HSCT). The data from the trial suggest a significant improvement in 180 Day Grade III-IV acute GVHD-Free Survival, the primary endpoint for the Phase III clinical trial called CATHY. CD24Fc prophylaxis also resulted in reduced Relapse and demonstrated improvement in Overall Survival, Non-Relapse Mortality and Relapse-Free Survival, as compared with the controls. A dose-dependent reduction in severe (Grade > 3) mucositis was also observed. A 20 patients open label dose expansion cohort at the recommended clinical dose has been fully enrolled and the CD24Fc continues to perform very well. The Phase III study for the prevention of aGVHD is being initiated nationwide. The CD24Fc programs have been partially funded by the National Institutes of Health and the Food and Drug Administrations.

View post:
OncoImmune’s SACCOVID (CD24Fc) Exhibits Superb Therapeutic EfficacyA Potential Breakthrough in Treating Severe and Critical COVID-19 – Business Wire

Former NFL star Eddie George returns to Vero Beach for therapy, this time on shoulder – TCPalm

Eddie George was in Vero Beach, Florida, on September 19, 2020, for a medical procedure and discussed the return of Big 10 football. Gannett Staff

VERO BEACH Stem cell and plasma therapy brought a former NFL player to Vero Beach to soothe his ailing knees a few years ago.

Now, he’s just looking for a good night’s sleep, all because of a nagging shoulder injury. And the same specialists in Vero said they could help him with that, too.

On Saturday, Eddie George, who was a Heisman Trophy winner at Ohio State University and one of the initial stars of the Tennessee Titans, made another trip to Regenerative Biologistics Institute in Vero Beach for treatment. The first time, in July 2018, was to help his knees.

“Walking was a chore,let alone trying to jog,” said George, 47, who still lives in the Nashville area.

But now he’s walking, swimming and doing enough exercise that he returned to the institute Saturday lighter than he was previously. George said he lost 20 pounds this year.

“My joints have been great,” said the now 244-pound, 6-feet-3 former athlete. “I feel a lot better.”

Former professional football player Eddie George shares a laugh with regenerative medicine specialists Jason Griffeth (left) and Brett Haake on Saturday, Sept. 19, 2020, as he prepares to receive stem cell and growth factor injections in both knees and right shoulder at Regenerative Biologics Institute in Vero Beach. “What the injections will do is decrease inflammation, decrease pain and increase functionality,” said Haake, medical director for the institute. “We’re focusing on longevity. We’re focusing on optimizing someone’s functionality and minimizing their morbidity. We focus on prevention and intervening disease states earlier rather than later.” George suffered several injuries during his time playing football.(Photo: PATRICK DOVE/TCPALM)

What doesn’t feel better is a shoulder injury he has had since his freshman year with the Ohio State Buckeyes. George chose to have a stem cell injection inhis shoulder Saturday.

“There’s a piece missing from my right shoulder socket,” George said. “The integrity of the joint there has been compromised. I don’t have a lot of flexibility there. When I sleep at night, it gets aggravated and I have to constantly move to get adjusted.”

RBI Medical Director Dr. Brett Haake also gave George more injections to his knees Saturday. George had surgery on one of them in March to remove bone spurs.

The institute isat 3755 Seventh Terrace, just north of the Cleveland Clinic Indian River Hospitalin Vero Beach. Clinical director Jason Griffeth said his office uses Regenmax Injection Therapy, which transfers stem cells from a person’s abdomen to parts of the body where the patient is feeling pain.

The regenerative abilities of the stem cells repair the injured tissue in areas lacking those cells, said Griffeth, whose office opened in 2016.

“The stem cells areanti-inflammatory and very regenerative,” Haake said.

More: SWV star Taj George gets stem cell treatment for knees in Vero Beach

George’s R&B star wife, Tamara “Taj” George of the group SWV, also had the procedure done on her knees last year. She said years on stage have damaged her knees, but the stem cell therapy allows her to run now.

“I gained a little bit of weight during this quarantine, but I’m still able to run,” she said in a phone call Saturday.

Eddie George is recommending the procedure to other athletes, active or retired.

“This can prolong their careers and their lifestyle after they’re done playing,” he said.

Autoplay

Show Thumbnails

Show Captions

In retirement, George runs a wealth management company and will be commenting on college football on ESPN’s XM Satellite Radio station a few days a week, he said.

The institute recommends its therapy for arthritis, torn rotator cuffs, meniscus injuries and bursitis.

On the web: rbistemcell.com

More: Miami Dolphins to allow 13,000 fans to home opener vs. Bills at Hard Rock Stadium

LamaurStancilis the Treasure Coast regional economy reporter covering businessand industries, including retail, tourism and hospitality.Contact him at 321-987-7179 orlamaur.stancil@tcpalm.com and follow him at Lamaur Stancil on Facebook and @TCPalmLStancil on Twitter.

To stay up to date with ourexclusive content, be sure tosubscribe.

Read or Share this story: https://www.tcpalm.com/story/news/local/indian-river-county/2020/09/20/ex-nfl-star-eddie-george-returns-vero-beach-therapy-shoulder/5823079002/

View post:
Former NFL star Eddie George returns to Vero Beach for therapy, this time on shoulder – TCPalm

Market Players Eye Opportunities in Emerging Economies to Gain Ground in the Stem Cell Therapy Market2020 – The Daily Chronicle

The ever-evolving Coronavirus (COVID-19) has caused interruptions in supply chains of companies in the Stem Cell Therapy market. Through careful analysis of the COVID-19, our analysts at PMR offer you a birds eye view of the current on goings of top tier companies in the Stem Cell Therapy market. Learn how leading companies are striking potential partnership agreements to generate sales in the Stem Cell Therapy market.

Assessment of the Global Stem Cell Therapy Market

The recently published market study on the global Stem Cell Therapy market by Persistence Market Research (PMR) offers an elaborate analysis of the different market parameters that are poised to influence the overall dynamics of the Stem Cell Therapy market. Further, the study reveals that the global Stem Cell Therapy market is forecasted to grow at a CAGR of ~XX% through the forecast period (20XX-20XX) and reach a market value of ~US$ by the end of 20XX.

The presented study provides critical insights related to the future prospects of the Stem Cell Therapy market by analyzing the different segments and sub-segments of the Stem Cell Therapy market. Further, the report is divided into different sections to provide readers a clear understanding of the different aspects of the Stem Cell Therapy market.

Request Sample Report @ https://www.persistencemarketresearch.co/samples/3253

Critical insights enclosed in the report:

Important market segments included in the report:

Some of the major companies operating in the global stem cell therapy market are Mesoblast Ltd., Celgene Corporation, Aastrom Biosciences, Inc. and StemCells, Inc.

Key points covered in the report

Request Report Methodology @ https://www.persistencemarketresearch.co/methodology/3253

The market study addresses the following queries related to the global Stem Cell Therapy market:

For any queries get in touch with Industry Expert @ https://www.persistencemarketresearch.co/ask-an-expert/3253

Why Purchase From Persistence Market Research?

Here is the original post:
Market Players Eye Opportunities in Emerging Economies to Gain Ground in the Stem Cell Therapy Market2020 – The Daily Chronicle

Stem Cell Therapy Market- Roadmap for Recovery from COVID-19 | Increase in Awareness of Stem Cell Therapy to boost the Market Growth | Technavio -…

LONDON–(BUSINESS WIRE)–Technavio has been monitoring the stem cell therapy market and it is poised to grow by USD 588.22 million during 2020-2024, progressing at a CAGR of almost 7% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavios in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report on COVID-19 Impacts

Frequently Asked Questions-

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Gilead Sciences Inc., Holostem Terapie Avanzate Srl, Lineage Cell Therapeutics Inc., Lonza Group Ltd., Novartis AG, Nuvasive Inc., Organogenesis Inc., Osiris Therapeutics Inc., RTI Surgical Holdings Inc., and Vericel Corp. are some of the major market participants. The increase in awareness of stem cell therapy will offer immense growth opportunities. To make most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Technavio’s custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations.

Stem Cell Therapy Market 2020-2024: Segmentation

Stem Cell Therapy Market is segmented as below:

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43432

Stem Cell Therapy Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The stem cell therapy market report covers the following areas:

This study identifies a limited number of FDA-approved stem cell therapies as one of the prime reasons driving the stem cell therapy market growth during the next few years.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform

Stem Cell Therapy Market 2020-2024: Key Highlights

Table of Contents:

Executive Summary

Market Landscape

Market Sizing

Five Forces Analysis

Market Segmentation by Type

Customer landscape

Geographic Landscape

Vendor Landscape

Vendor Analysis

Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

See the article here:
Stem Cell Therapy Market- Roadmap for Recovery from COVID-19 | Increase in Awareness of Stem Cell Therapy to boost the Market Growth | Technavio -…

Canine Stem Cell Therapy Industry Revenue Analysis with Impact of COVID19 – PharmiWeb.com

Canine stem cell therapy is a disease-modifying therapy used for the treatment of degenerative disorders such as arthritis of hips, elbows, shoulders, etc.

Factors like rising prevalence of canine arthritis and increasing investment in research and development are expected to accentuate the growth of the canine stem cell therapy market. However, stem cell therapy is an expensive procedure as compared to other treatment options and this is impeding the growth of the market. Moreover, the lack of pet insurance will further restrain the growth of the market.

Based on type, the global canine stem cell therapy market has been segmented into autologous stem cells and allogeneic stem cells. The autologous stem cells segment accounts for more than 80% of the global canine stem cell therapy market. This segment is expected to reach $xx million by 2026 from $xx in 2019, growing at a significant rate

Based on applications, the market has been segmented into treatment and research. The treatment segment accounts for the largest share in the global canine stem cell therapy market by application.

Based on the end-user, the market has been segmented into veterinary hospitals, veterinary clinics, and veterinary research institutes. The veterinary clinics segment accounts for the largest share in the market and held more than 60% of the total market in 2018.

North America accounted for the highest share in 2018 and is expected to continue its dominance in the market throughout the forecast period. North America has the highest population of pet dogs, with around 73 million dogs in the US and over 6 million in Canada. The rising pet ownership in this region is one of the most important factors driving the growth of this market. The US accounted for around 90% of the market in 2018. The rising research and development activity in this region will also augment the growth of the canine stem cell therapy market.

Company Profiles and Competitive Intelligence:

The major players operating in this market are VetStem Biopharma, Medrego, and Magellan Stem Cells, amongst others. Most of the companies are conducting clinical trials to study the safety and efficacy of stem cells for various indication such as spinal disorders, renal disorders, etc.

Source @ https://inforgrowth.com/report/6322118/canine-stem-cell-therapy-market

About InForGrowth: We are a market-intelligence company formed with the objective of providing clients access to the most relevant and accurate research content for their growth needs. At InForGrowth, we understand Research requirements and help a client in taking informed business critical decisions. Given the complexities and interdependencies ofmarket-intelligence, there is always more than one source to explore and arrive at the right answer. Through our smart search feature and our reliable & trusted publishing partners, we are paving way for a more simplified and relevant research

For all your Research needs, reach out to us at: Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USA Contact Person: Rohan Email: sales@inforgrowth.com US: +1-909-329-2808 UK: +44 (203) 743 1890

market-intelligence, there is always more than one source to explore and arrive at the right answer. Through our smart search feature and our reliable & trusted publishing partners, we are paving way for a more simplified and relevant research

For all your Research needs, reach out to us at: Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USA Contact Person: Rohan Email: sales@inforgrowth.com US: +1-909-329-2808 UK: +44 (203) 743 1890

More:
Canine Stem Cell Therapy Industry Revenue Analysis with Impact of COVID19 – PharmiWeb.com

The Holistic Sanctuary Announces Exciting Plans to Expand Over Next 4 Years and Save More Lives – WFMZ Allentown

BEVERLY HILLS, Calif., Sept. 19, 2020 /PRNewswire/ — The Holistic Sanctuary is proud to announce its exciting plans to grow the number of cutting-edge luxury centers it has over the next four years, allowing it to help even more patients in need of its pioneering treatments.

After a decade of revolutionizing the holistic health field and saving lives, The Holistic Sanctuary, which currently has a state-of-the-art facility in Baja California (Mexico), plans to open another center in Tulum, Mexico, as well as an additional three centers in several other locations around the world.

Holistic Sanctuary Tulum is well on its way to opening its doors in 2021, which will be followed by plans to open other centers in Tulum (2021), Malibu (2022), London (2023) and Dubai (2024).

The Holistic Sanctuary is a world-class holistic medical spa that uses cutting-edge technology and advanced therapies from around the world to cure, heal, and reverse illnesses and diseases that Western medical professionals have said are incurable. By using a combination of natural therapies, they help people to recover from a variety of different conditions such as depression, addiction, PTSD, stress, anxiety, and more.

Johnny Tabaie, CEO and Founder of The Holistic Sanctuary, said:”We are incredibly excited that we will soon be able to help even more patients around the world. We’ve taken holistic healing to a whole different level, and our intention has always been to heal patients using natural, effective, holistic and other alternative therapies that give results in real-time, without having to medicate people with addictive drugs.

“We simplytransform people’s lives; we give them a fighting chance at a good quality oflife. We get people off prescribed medications, heal the underlying cause of PTSD, depression, trauma and even addiction, then send them back home healthy, thriving, happy and whole again.”

More information on The Holistic Sanctuary’s luxury drug rehab centers can be found at https://www.theholisticsanctuary.com/luxury-rehab-centers/

In addition to its growth plans, the organization has also announced that by the end of 2020 it will have the first AIDS and cancer research center that will strive to cure diseases like this using revolutionary stem cell technology. It will also be able to treat other autoimmune conditions such as lupus, rheumatoid arthritis, Lyme disease, neuropathy, multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS).

This kind of cutting technology has been around for the last 30 years, revolutionizing how illnesses like these are treated through the discovery of isolated stem cell genes that have been proven clinically to showit has cured two patients suffering from AIDS and cancer. One has been clear for 10 years now, with the other being cured last year. This is a new, paradigm-shifting approach that is pushing western medication treatment to the side.

To learn about how stem cell technology is used by the centers, more information can be found here: https://www.theholisticsanctuary.com/stem-cell-therapy/

Learn more about The Holistic Sanctuary’s Mexico stem cell center here: https://www.theholisticsanctuary.com/stem-cell-therapy/mexico/

The Holistic Sanctuary has an 80% success rate at healing patients that are either on medications, alcohol, street drugs, or suffer from mental health disorders such as PTSD, depression, anxiety and trauma. See more information on what treatments are used for these:

“We’ve incorporated holistic medicine and methodically weaved it with sacred plant medicine to have a better synergistic never before seen outcome. In the last 10 years, we have therapeutically, safely and humanely given people sacred plant medicines like Ibogaine, DMT, Changa, 5-MEO, Kambo, Psilocybin, mushrooms, and much more,”added Tabaie.

The organization is looking for investors and partners to help finance and push this revolutionary vision forward. For more information about The Holistic Sanctuary and investor relations, please send an email or call +1-310-601-7805 or visit their website at www.theholisticsanctuary.com.

About The Holistic Sanctuary

The Holistic Sanctuary is a world-class holistic medical spa that uses cutting-edge and advanced therapies from around the world. It uses powerful modalities to cure, heal, and reverse illnesses and diseases that Western medical professionals have said are incurable. It is not a drug rehab, more along the lines of a luxury treatment center that transforms lives. It helps people to recover from depression, any type of addiction, PTSD, stress, anxiety, as well as other mental health problems. The centers use a combination of natural therapies to help people recover mentally, physically and emotionally. Unlike mainstream doctors, rehabs, and treatment centers, The Holistic Sanctuary avoids the use of outdated theories, ineffective therapies and addiction to toxic medications and drugs. Instead, it addresses the root causes of these illnesses, improves physical and mental health and alleviates the illnesses.

Media Contact

Company Name: The Holistic Sanctuary

Contact Person: Investor Relations

Email: info@theholisticsanctuary.com

Phone: +1-310-601-7805

Address: 1212 Wilshire Blvd.

City:Beverly Hills

State:California

Website: www.theholisticsanctuary.com

Related Images

the-holistic-sanctuary.png The Holistic Sanctuary Most Exclusive Healing Center In The World, The Holistic Sanctuary Healing Center Offers Holistic Stem Cells, Plant Medicine and Powerful Therapies for Lupus, Lyme, MS, ALS, Addiction, Depression, PTSD, Stem Cell Therapies to Heal Clients Naturally

Related Video

Visit link:
The Holistic Sanctuary Announces Exciting Plans to Expand Over Next 4 Years and Save More Lives – WFMZ Allentown

Cord Stem Cell Banking Market Analysis 2020 With COVID 19 Impact Analysis| Leading Players, Business Prospects, In-depth Analysis Research Report…

Global stem cell banking market is set to witness a substantial CAGR of 11.03% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. The increased market growth can be identified by the increasing procedures of hematopoietic stem cell transplantation (HSCT), emerging technologies for stem cell processing, storage and preservation. Increasing birth rates, awareness of stem cell therapies and higher treatment done viva stem cell technology.

Get Sample Report + All Related Graphs & Charts (with COVID 19 Analysis) @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-stem-cell-banking-market&pm

Competitive Analysis:

Global stem cell banking market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of inflammatory disease drug delivery market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major competitors currently working in global inflammatory disease drug delivery market are: NSPERITE N.V, Caladrius, ViaCord, CBR Systems, Inc, SMART CELLS PLUS, LifeCell International, Global Cord Blood Corporation, Cryo-Cell International, Inc., StemCyte India Therapeutics Pvt. Ltd, Cordvida, ViaCord, Cryoviva India, Vita34 AG, CryoHoldco, PromoCell GmbH, Celgene Corporation, BIOTIME, Inc., BrainStorm Cell Therapeutics and others

Market Definition:Global Stem Cell Banking Market

Stem cells are cells which have self-renewing abilities and segregation into numerous cell lineages. Stem cells are found in all human beings from an early stage to the end stage. The stem cell banking process includes the storage of stem cells from different sources and they are being used for research and clinical purposes. The goal of stem cell banking is that if any persons tissue is badly damaged the stem cell therapy is the cure for that. Skin transplants, brain cell transplantations are some of the treatments which are cured by stem cell technique.

Cord Stem Cell Banking MarketDevelopment and Acquisitions in 2019

In September 2019, a notable acquisition was witnessed between CBR and Natera. This merger will develop the new chances of growth in the cord stem blood banking by empowering the Nateras Evercord branch for storing and preserving cord blood. The advancement will focus upon research and development of the therapeutic outcomes, biogenetics experiment, and their commercialization among the global pharma and health sector.

Cord Stem Cell Banking MarketScope

Cord Stem Cell Banking Marketis segmented on the basis of countries into U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

All country based analysis of the cord stem cell banking marketis further analyzed based on maximum granularity into further segmentation. On the basis of storage type, the market is segmented into private banking, public banking. On the basis of product type, the market is bifurcated into cord blood, cord blood & cord tissue. On the basis of services type, the market is segmented into collection & transportation, processing, analysis, storage. On the basis of source, market is bifurcated into umbilical cord blood, bone marrow, peripheral blood stem, menstrual blood. On the basis of indication, the market is fragmented into cerebral palsy, thalassemia, leukemia, diabetes, autism.

Cord stem cell trading is nothing but the banking of the vinculum plasma cell enclosed in the placenta and umbilical muscle of an infant. This ligament plasma comprises the stem blocks which can be employed in the forthcoming time to tackle illnesses such as autoimmune diseases, leukemia, inherited metabolic disorders, and thalassemia and many others.

Market Drivers

Increasing rate of diseases such as cancers, skin diseases and others Public awareness associated to the therapeutic prospective of stem cells Growing number of hematopoietic stem cell transplantations (HSCTs) Increasing birth rate worldwide

Market Restraint

High operating cost for the therapy is one reason which hinders the market Intense competition among the stem cell companies Sometimes the changes are made from government such as legal regulations

Key Pointers Covered in the Cord Stem Cell Banking MarketIndustry Trends and Forecast to 2026

Market Size Market New Sales Volumes Market Replacement Sales Volumes Market Installed Base Market By Brands Market Procedure Volumes Market Product Price Analysis Market Healthcare Outcomes Market Cost of Care Analysis Market Regulatory Framework and Changes Market Prices and Reimbursement Analysis Market Shares in Different Regions Recent Developments for Market Competitors Market Upcoming Applications Market Innovators Study

Key Developments in the Market:

In August, 2019, Bayer bought BlueRock for USD 600 million to become the leader in stem cell therapies. Bayer is paying USD 600 million for getting full control of cell therapy developer BlueRock Therapeutics, promising new medical area to revive its drug development pipeline and evolving engineered cell therapies in the fields of immunology, cardiology and neurology, using a registered induced pluripotent stem cell (iPSC) platform. In August 2018, LifeCell acquired Fetomed Laboratories, a provider of clinical diagnostics services. The acquisition is for enhancement in mother & baby diagnostic services that strongly complements stem cell banking business. This acquisition was funded by the internal accruals which is aimed to be the Indias largest mother & baby preventive healthcare organization.

For More Insights Get FREE Detailed TOC @https://www.databridgemarketresearch.com/toc/?dbmr=global-stem-cell-banking-market&pm

Research objectives

To perceive the most influencing pivoting and hindering forces in Cord Stem Cell Banking Market and its footprint in the international market. Learn about the market policies that are being endorsed by ruling respective organizations. To gain a perceptive survey of the market and have an extensive interpretation of the Cord Stem Cell Banking Market and its materialistic landscape. To understand the structure of Cord Stem Cell Banking Market by identifying its various sub segments. Focuses on the key global Cord Stem Cell Banking Market players, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). To project the consumption of Cord Stem Cell Banking Market submarkets, with respect to key regions (along with their respective key countries). To strategically profile the key players and comprehensively analyze their growth strategies To analyze the Cord Stem Cell Banking Market with respect to individual growth trends, future prospects, and their contribution to the total market.

Customization of the Report:

All segmentation provided above in this report is represented at country level All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email @[emailprotected]

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

See the original post:
Cord Stem Cell Banking Market Analysis 2020 With COVID 19 Impact Analysis| Leading Players, Business Prospects, In-depth Analysis Research Report…

Stem Cell Therapy Products Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19…

The globalStem Cell Therapy Products Marketis carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Stem Cell Therapy Products market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global Stem Cell Therapy Products market. With qualitative and quantitative analysis, we help you with thorough and comprehensive research on the global Stem Cell Therapy Products market. We have also focused on SWOT, PESTLE, and Porters Five Forces analyses of the global Stem Cell Therapy Products market.

Leading players of the global Stem Cell Therapy Products market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global Stem Cell Therapy Products market. Furthermore, the report offers two separate market forecasts one for the production side and another for the consumption side of the global Stem Cell Therapy Products market. It also provides useful recommendations for new as well as established players of the global Stem Cell Therapy Products market.

To know How COVID-19 Pandemic Will Impact This Market/Industry -Request sample copy of this report: https://www.reportsandmarkets.com/sample-request/global-and-chinese-stem-cell-therapy-products-industry-2018-market-research-report?utm_source=verdant-news&utm_medium=24

Major Players: ask for sample

Regions and Countries:U.S, Canada, France, Germany, UK, Italy, Rest of Europe, India, China, Japan, Singapore, South Korea, Australia, Rest of APAC, Brazil, Mexico, Argentina, Rest of LATAM, Saudi Arabia, South Africa, UAE.

Report Objectives

For More Information or Query or Customization Before Buying, Visit at -: https://www.reportsandmarkets.com/sample-request/global-and-chinese-stem-cell-therapy-products-industry-2018-market-research-report?utm_source=verdant-news&utm_medium=24

Table of Contents

Report Overview:It includes major players of the global Stem Cell Therapy Products market covered in the research study, research scope, and Market segments by type, market segments by application, years considered for the research study, and objectives of the report.

Global Growth Trends:This section focuses on industry trends where market drivers and top market trends are shed light upon. It also provides growth rates of key producers operating in the global Stem Cell Therapy Products market. Furthermore, it offers production and capacity analysis where marketing pricing trends, capacity, production, and production value of the global Stem Cell Therapy Products market are discussed.

Market Share by Manufacturers:Here, the report provides details about revenue by manufacturers, production and capacity by manufacturers, price by manufacturers, expansion plans, mergers and acquisitions, and products, market entry dates, distribution, and market areas of key manufacturers.

Market Size by Type:This section concentrates on product type segments where production value market share, price, and production market share by product type are discussed.

Market Size by Application:Besides an overview of the global Stem Cell Therapy Products market by application, it gives a study on the consumption in the global Stem Cell Therapy Products market by application.

Production by Region:Here, the production value growth rate, production growth rate, import and export, and key players of each regional market are provided.

Consumption by Region:This section provides information on the consumption in each regional market studied in the report. The consumption is discussed on the basis of country, application, and product type.

Company Profiles:Almost all leading players of the global Stem Cell Therapy Products market are profiled in this section. The analysts have provided information about their recent developments in the global Stem Cell Therapy Products market, products, revenue, production, business, and company.

Market Forecast by Production:The production and production value forecasts included in this section are for the global Stem Cell Therapy Products market as well as for key regional markets.

Market Forecast by Consumption:The consumption and consumption value forecasts included in this section are for the global Stem Cell Therapy Products market as well as for key regional markets.

Value Chain and Sales Analysis:It deeply analyzes customers, distributors, sales channels, and value chain of the global Stem Cell Therapy Products market.

Key Findings:This section gives a quick look at important findings of the research study.

About Us:

Market research is the new buzzword in the market, which helps in understanding the market potential of any product in the market. Reports And Markets is not just another company in this domain but is a part of a veteran group called Algoro Research Consultants Pvt. Ltd. It offers premium progressive statistical surveying, market research reports, analysis & forecast data for a wide range of sectors both for the government and private agencies all across the world.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

www.reportsandmarkets.com

[emailprotected]

Ph: +1-352-353-0818 (US)

Go here to see the original:
Stem Cell Therapy Products Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19…